Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 738: 374-83, 2014 Sep 05.
Article in English | MEDLINE | ID: mdl-24930813

ABSTRACT

Methylglyoxal (MGO), a glucose derived dicarbonyl intermediate, is a major precursor of advanced glycation end products (AGEs) which have been linked to the development of diabetic cataract. Protocatechualdehyde (PCA), a phenolic acid compound, is found in the roots of Salvia miltiorrhiza. This study was to investigate the effect of PCA against MGO-induced cytotoxicity in human lens epithelial cells (SRA01/04 cells) and the possible involved molecular mechanism. The results showed that PCA alleviated MGO-induced mitochondrial dysfunction and apoptosis in SRA01/04 cells. Furthermore, PCA was capable of inhibiting MGO-mediated AGEs formation and blocking receptor of AGEs expression in SRA01/04 cells. It is concluded that PCA could be useful in attenuation of MGO-induced cell damage and the possible mechanism is involved in modulating AGEs-receptor of AGEs axis in human lens epithelial cells, which suggests that PCA has a potential protective effect on diabetic cataract.


Subject(s)
Benzaldehydes/pharmacology , Catechols/pharmacology , Epithelial Cells/drug effects , Glycation End Products, Advanced/metabolism , Lens, Crystalline/cytology , Mitochondria/drug effects , Pyruvaldehyde/toxicity , Receptors, Immunologic/metabolism , Apoptosis/drug effects , Cytoprotection/drug effects , DNA Damage , Epithelial Cells/cytology , Epithelial Cells/metabolism , Gene Expression Regulation/drug effects , Humans , Mitochondria/metabolism , Receptor for Advanced Glycation End Products
SELECTION OF CITATIONS
SEARCH DETAIL
...